GHK-Cu vs AHK-Cu

Evidence-based comparison. Updated 2026.

GHK-Cu has broader research support (Evidence Grade B) and is the more established choice for wound healing, anti-aging, and collagen stimulation via topical or systemic use. AHK-Cu shares overlapping mechanisms but carries only a Grade D evidence rating, meaning its benefits are less independently validated. Researchers prioritizing documented outcomes typically favor GHK-Cu, while AHK-Cu may be explored as an adjunct or alternative when GHK-Cu is insufficient.

Side by side

	GHK-Cu	AHK-Cu
Evidence	BEvidenceGrade BSmaller human trials or observational studies, or approved in 30+ countries	DEvidenceGrade DTheoretical or in-vitro only, with no meaningful independent human evidence
Regulatory	Research onlyResearch onlyNo regulatory approval in any major jurisdiction. For research use only	Research onlyResearch onlyNo regulatory approval in any major jurisdiction. For research use only
Benefits	Wound healing and skin regeneration Anti-aging and collagen production Hair growth stimulation Anti-inflammatory properties Improves skin elasticity and firmness	Promotes collagen synthesis and tissue repair Reduces inflammation and supports wound healing Enhances skin elasticity and firmness Supports hair growth and follicle health Improves skin hydration and barrier function
Dosage	1-3 mg (injectable) or 1-3% (topical) mg, 2-3x/week (injectable) or daily (topical)	50-200 mcg, 1x daily
Route	Subcutaneous, Topical	Subcutaneous
Category	Skin & Anti-Aging	Healing & Recovery

Full research page

GHK-Cu

Full research page

AHK-Cu

Which should you choose

GHK-Cu and AHK-Cu are both copper-bound tripeptides that signal fibroblasts to upregulate collagen and elastin, but GHK-Cu has a substantially larger body of published research behind its mechanisms, while AHK-Cu is structurally related yet lacks comparable independent validation.

Choose GHK-Cu when

Higher evidence grade (B vs D) means more peer-reviewed data supporting its wound healing and collagen synthesis effects
Well-characterized mechanism across multiple pathways including angiogenesis, dermal remodeling, and antioxidant activity
Established topical and systemic use cases with a longer research history in skin regeneration and anti-aging protocols

Choose AHK-Cu when

May serve as an alternative in research contexts where GHK-Cu response is insufficient or a structurally distinct copper peptide is desired
Reported to modulate MMP activity in a controlled manner, which may be relevant for specific tissue remodeling research questions
Shares collagen synthesis and hair follicle support properties, potentially useful in dual-administration protocols alongside established peptides

Stacking GHK-Cu and AHK-Cu is not a widely documented or validated practice in the published literature, and their overlapping mechanisms make additive benefit uncertain without direct comparative or combination study data.

Questions people ask

Do GHK-Cu and AHK-Cu work through the same mechanism, and does that affect which one to choose?

Both peptides share core mechanisms: copper-mediated upregulation of collagen and elastin gene expression in fibroblasts, promotion of angiogenesis, and modulation of inflammatory cytokines. However, GHK-Cu has been studied across a wider range of cellular pathways and has more published mechanistic data. If mechanism specificity matters for a research protocol, GHK-Cu offers more documented pathway detail to work from.

Is there a meaningful difference in timeline to observable effects between GHK-Cu and AHK-Cu?

No direct head-to-head timeline studies exist comparing the two peptides. GHK-Cu studies in skin and wound healing contexts typically report observable changes over weeks of consistent application or administration. AHK-Cu lacks equivalent longitudinal study data, making it difficult to draw reliable timeline comparisons between the two compounds at this stage of research.

Can GHK-Cu and AHK-Cu be used together in a research protocol, or is one generally sufficient?

Because both peptides target overlapping receptors and downstream pathways, combining them does not have established synergistic evidence in the current literature. Most published research focuses on GHK-Cu in isolation. Using AHK-Cu alongside GHK-Cu would represent an unvalidated approach, and the potential for redundancy rather than complementarity is a reasonable concern given their structural and mechanistic similarities.

Which peptide has stronger evidence for hair growth specifically, GHK-Cu or AHK-Cu?

GHK-Cu has more published research relevant to hair follicle stimulation, including studies examining its effects on follicle cycling and dermal papilla cell activity. AHK-Cu is noted to support hair follicle health in its research profile, but the evidence base is considerably thinner and less replicated. For hair growth as a primary research endpoint, GHK-Cu represents the better-supported option based on current data.

Not sure which fits your research goals?

Use the goal finder

Answer three questions and get a peptide recommendation ranked by evidence grade.

Find my peptide